Novavax (NVAX) signed a deal with drugmaker Sanofi to co-commercialize the Covid Vaccine. Diane King Hall discusses this, as well as Novavax’s 1Q earnings. Its adjusted EPS came in at -$1.05 versus an estimated -$1.06 and revenue came in at $93.9M versus an estimated $101.2M. Tune in to find out more about the stock market today.